Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase II Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD

This study has been completed.
The Leukemia and Lymphoma Society
Information provided by:
Stanford University Identifier:
First received: September 14, 2005
Last updated: March 11, 2011
Last verified: March 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2010
  Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):